NASDAQ:NEO NeoGenomics Q3 2026 Earnings Report $18.32 +0.54 (+3.04%) As of 03:01 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast NeoGenomics EPS ResultsActual EPSN/AConsensus EPS $0.06Beat/MissN/AOne Year Ago EPSN/ANeoGenomics Revenue ResultsActual RevenueN/AExpected Revenue$205.89 millionBeat/MissN/AYoY Revenue GrowthN/ANeoGenomics Announcement DetailsQuarterQ3 2026Date10/27/2026TimeBefore Market OpensConference Call DateTuesday, October 27, 2026Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile NeoGenomics Earnings HeadlinesReviewing Omada Health (NASDAQ:OMDA) & NeoGenomics (NASDAQ:NEO)October 1 at 4:58 AM | americanbankingnews.com3 reasons NEO is risky and 1 stock to buy insteadSeptember 22, 2026 | msn.comA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio.October 2 at 1:00 AM | Stansberry Research (Ad)NeoGenomics (NEO) Expands Precision Oncology Focus, Is The Stock Fairly Valued?September 22, 2026 | finance.yahoo.comIs NeoGenomics’ (NEO) Community NGS Push Quietly Redefining Its Core Earnings Engine?September 21, 2026 | finance.yahoo.comNeoGenomics, Inc. (NEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 15, 2026 | seekingalpha.comSee More NeoGenomics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like NeoGenomics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeoGenomics and other key companies, straight to your email. Email Address About NeoGenomicsNeoGenomics (NASDAQ:NEO) (NASDAQ:NEO) is a specialized oncology diagnostics company that provides testing services to hospitals, physicians, pathologists, pharmaceutical companies and other healthcare organizations. Its services support the diagnosis, classification and monitoring of cancer, helping guide treatment decisions and drug development. The company offers a broad range of pathology and laboratory services, including molecular testing, next-generation sequencing, fluorescence in situ hybridization, cytogenetics, flow cytometry, immunohistochemistry and digital pathology. NeoGenomics also provides clinical trial and biopharmaceutical services, including central laboratory testing, biomarker analysis and other support for oncology drug development programs. Founded in 1999, NeoGenomics has expanded through organic growth and acquisitions into a network serving customers primarily in the United States, with additional international capabilities. The company operates specialized laboratories and supports testing across a variety of solid tumors and hematologic cancers. Its leadership includes President and Chief Executive Officer Chris Smith.View NeoGenomics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market ShareCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket Reach Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
